# Hsv 1 and 2 Gowey Protocol Versus Placebo

> **NCT01477879** · PHASE1,PHASE2 · COMPLETED · sponsor: **Naturopaths International** · enrollment: 33 (actual)

## Conditions studied

- Herpes

## Interventions

- **OTHER:** Versabase gel with sarracenia purpurea 20% liquid extract
- **OTHER:** placebo (versabase gel only)

## Key facts

- **NCT ID:** NCT01477879
- **Lead sponsor:** Naturopaths International
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2011-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477879, "Hsv 1 and 2 Gowey Protocol Versus Placebo". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01477879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*